Intrinsic Value

The intrinsic value of Genomtec SA (GMT) under the Base Case is PLN per share. Compared with the current market price of 2.5 PLN, the stock appears .

The intrinsic value is calculated using the DCF method.

Do our valuations actually work? See backtest results .

GMT Intrinsic Value

What one share is worth in the bear, base and bull cases.

Create a free account · No card needed

Do our valuations actually work? See backtest results .

Alert me when GMT is below its intrinsic value
Today Hidden ·
GMT Valuation History

Intrinsic value next to the price over the past 5 years.

Create a free account · No card needed

Alternatives to GMT

Fundamental Analysis

What Genomtec Does

Genomtec is a Polish life-science company that develops molecular diagnostics tools for detecting genetic material from pathogens and other biological samples. Its core work centers on laboratory and point-of-care testing systems, including the test cartridges and instruments needed to run them. The company sells its technology into healthcare and diagnostics, where fast and accurate identification of infections matters.

Headquarters
Poland PL
IPO date
Mar 17, 2021
Read the full company overview
View Company Overview
Financials

Balance Sheet

Efficiency

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Recent Events

Past 12 months

Continue GMT Research

Decided on Genomtec? Get an email when GMT reaches the price you’d buy at. Free with an account.

Other Genomtec listings

What is the Intrinsic Value of one GMT stock?

The intrinsic value for Genomtec SA (GMT) under the Base Case is PLN.

Is GMT stock undervalued or overvalued?

Compared with the current market price of 2.5 PLN, the stock appears .

How reliable are our estimates? See how past valuations played out
Back to Top